Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study
Janet T Holbrook, Elizabeth A Sugar, Alyce E Burke, Albert T Vitale, Jennifer E Thorne, Janet L Davis, Douglas A Jabs
American Journal of Ophthalmology | ELSEVIER SCIENCE INC | Published : 2016
Awarded by National Eye Institute, National Institutes of Health, Bethesda, Maryland
SUPPORTED BY COLLABORATIVE AGREEMENTS U10 EY 014655 TO THE ICAHN SCHOOL OF MEDICINE AT Mount Sinai, New York, New York (Douglas A. Jabs), U10 EY 014660 to the Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland (Janet T. Holbrook), and U10 EY 014656 to the University of Wisconsin, Madison, School of Medicine and Public Health, Madison Wisconsin (Dr. Michael M. Altaweel) from the National Eye Institute, National Institutes of Health, Bethesda, Maryland. Bausch and Lomb, Inc (Bridgewater, New Jersey) provided a limited number of fluocinolone acetonide implants to the trial for use at centers without access to implants.